A simulated cell in the early stages of division. Left half shows membrane (green cubes), and ribosomes (yellow/purple) ...
CAR T-cell therapies are individualized treatments approved for multiple hematologic malignancies, with improved management of adverse effects over time. Access to CAR T-cell therapies is limited by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results